Author:
Matsumoto Takeshi,Masuo Yusuke,Tanaka Anna,Kimura Toshifumi,Ioroi Tadaaki,Yamakawa Tatsuya,Kitahara Hiromu,Kato Yukio
Funder
Fujifilm Holdings Corporation
Japan Society for the Promotion of Science
Reference40 articles.
1. Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer;Achiwa;Cancer Sci.,2004
2. Drug delivery systems: entering the mainstream;Allen;Science,2004
3. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice;Baxter;Cancer Res.,1994
4. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology;Bertrand;Adv. Drug Deliv. Rev.,2014
5. Modulation of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine;Beumer;Clin. Cancer Res.,2008
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献